Charles Schwab’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-412,334
Closed -$49.5K 3545
2024
Q4
$49.5K Hold
412,334
﹤0.01% 3439
2024
Q3
$56.6K Hold
412,334
﹤0.01% 3405
2024
Q2
$60.3K Hold
412,334
﹤0.01% 3495
2024
Q1
$60.2K Hold
412,334
﹤0.01% 3351
2023
Q4
$82.5K Hold
412,334
﹤0.01% 3361
2023
Q3
$68.9K Hold
412,334
﹤0.01% 3380
2023
Q2
$82.5K Hold
412,334
﹤0.01% 3363
2023
Q1
$87.3K Buy
+412,334
New +$101K ﹤0.01% 3268
2022
Q4
Sell
-343,967
Closed -$73K 3628
2022
Q3
$73K Hold
343,967
﹤0.01% 3257
2022
Q2
$76K Hold
343,967
﹤0.01% 3319
2022
Q1
$116K Hold
343,967
﹤0.01% 3392
2021
Q4
$106K Hold
343,967
﹤0.01% 3433
2021
Q3
$181K Hold
343,967
﹤0.01% 3339
2021
Q2
$287K Hold
343,967
﹤0.01% 3248
2021
Q1
$544K Buy
+343,967
New +$562K ﹤0.01% 3048
2019
Q2
Sell
-73,900
Closed -$26K 3293
2019
Q1
$26K Hold
73,900
﹤0.01% 3187
2018
Q4
$91K Hold
73,900
﹤0.01% 3096
2018
Q3
$139K Hold
73,900
﹤0.01% 3104
2018
Q2
$167K Buy
+73,900
New +$148K ﹤0.01% 3081

Other funds holding ZOM

Charles Schwab's ZOM Position: Q1 2025 in Review

Charles Schwab sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 412,334 shares — an estimated $49.5K sold.

Charles Schwab first reported a position in ZOM in Q2 2018 and held it in 19 quarters. The position peaked at $544K in Q1 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Charles Schwab reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Charles Schwab sold 412,334 Zomedica Corp. shares in Q1 2025, an estimated $49.5K.
  • Charles Schwab first reported a position in Zomedica Corp. in Q2 2018 and held it in 19 quarters.
  • Charles Schwab's Zomedica Corp. position peaked at $544K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.